Impaired nocturnal synthesis of melatonin in patients with cardiac syndrome X
dc.authorid | Altun, Armagan/0000-0002-3233-8263 | |
dc.authorid | vardar, selma arzu/0000-0002-1073-1718 | |
dc.authorwosid | AKTOZ, MERYEM/M-9023-2018 | |
dc.authorwosid | Altun, Armagan/ABB-5844-2020 | |
dc.contributor.author | Altun, A | |
dc.contributor.author | Yaprak, M | |
dc.contributor.author | Aktoz, M | |
dc.contributor.author | Vardar, A | |
dc.contributor.author | Betul, U | |
dc.contributor.author | Ozbay, G | |
dc.date.accessioned | 2024-06-12T11:09:05Z | |
dc.date.available | 2024-06-12T11:09:05Z | |
dc.date.issued | 2002 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | We investigated nocturnal secretion pattern of melatonin in patients with cardiac syndrome X and healthy subjects. The present study performed in five patients with cardiac syndrome X and in nine healthy controls. Blood samples from all subjects were collected every 2 h intervals between 22:00 and 08:00 h. Melatonin levels were measured with a radioimmunoassay kit. Patients with cardiac syndrome X secreted less nocturnal melatonin at 02:00 h than control subjects (P = 0.04). Peak and Delta melatonin (peak-lowest melatonin) were found lower in patients with cardiac syndrome X (P = 0.039 and P = 0.028, respectively). In conclusion patients with cardiac syndrome X show a markedly decreased nocturnal melatonin synthesis. Our study provides useful information about melatonin synthesis and release in patients with cardiac syndrome X might help physicians in managing these patients. (C) 2002 Published by Elsevier Science Ireland Ltd. | en_US |
dc.identifier.doi | 10.1016/S0304-3940(02)00368-3 | |
dc.identifier.endpage | 145 | en_US |
dc.identifier.issn | 0304-3940 | |
dc.identifier.issue | 2 | en_US |
dc.identifier.pmid | 12098655 | en_US |
dc.identifier.scopus | 2-s2.0-0037135288 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 143 | en_US |
dc.identifier.uri | https://doi.org/10.1016/S0304-3940(02)00368-3 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/22680 | |
dc.identifier.volume | 327 | en_US |
dc.identifier.wos | WOS:000177369800017 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Sci Ireland Ltd | en_US |
dc.relation.ispartof | Neuroscience Letters | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Nervous System | en_US |
dc.subject | Sympathovagal Imbalance | en_US |
dc.subject | Angina | en_US |
dc.subject | Normal Coronary Angiography | en_US |
dc.subject | Coronary-Artery Disease | en_US |
dc.subject | Heart-Disease | en_US |
dc.title | Impaired nocturnal synthesis of melatonin in patients with cardiac syndrome X | en_US |
dc.type | Article | en_US |